{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05233800",
            "orgStudyIdInfo": {
                "id": "4298"
            },
            "organization": {
                "fullName": "Medstar Health Research Institute",
                "class": "OTHER"
            },
            "briefTitle": "mHealth for Breast Cancer Survivors With Insomnia",
            "officialTitle": "Testing mHealth Delivery of Cognitive Behavioral Therapy for Insomnia to Breast Cancer Survivors",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Other"
            ],
            "study": "mhealth-for-breast-cancer-survivors-with-insomnia"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-04-05",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-01-20",
            "studyFirstSubmitQcDate": "2022-01-31",
            "studyFirstPostDateStruct": {
                "date": "2022-02-10",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-06-14",
            "lastUpdatePostDateStruct": {
                "date": "2023-06-18",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Hannah Arem",
                "investigatorTitle": "Scientific Director, Implementation Science",
                "investigatorAffiliation": "Medstar Health Research Institute"
            },
            "leadSponsor": {
                "name": "Medstar Health Research Institute",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Media Rez",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The aim of this study is to determine the impact of the voice-activated smart speaker CBT-I components on insomnia symptoms among breast cancer survivors using a randomized clinical trial.",
            "detailedDescription": "This study is a Phase II SBIR to further test efficacy of a voice-activated technology to deliver components of cognitive behavioral therapy for insomnia (CBT-I) to breast cancer survivors (BCS) compared to a web-based control. Participants will be randomly assigned to the voice-activated or web-based treatment arms and will complete a 6-week intervention."
        },
        "conditionsModule": {
            "conditions": [
                "Breast Cancer Survivor",
                "Insomnia"
            ],
            "keywords": [
                "Breast Cancer Survivor",
                "Insomnia",
                "mHealth",
                "Digital Health",
                "Cognitive Behavioral Therapy for Insomnia (CBT-I)"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "SUPPORTIVE_CARE",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 76,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Voice-Activated Smart Speaker Program",
                    "type": "EXPERIMENTAL",
                    "description": "Faster Asleep",
                    "interventionNames": [
                        "Behavioral: Faster Asleep Smart Speaker Program"
                    ]
                },
                {
                    "label": "Website",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Faster Asleep Website",
                    "interventionNames": [
                        "Behavioral: Faster Asleep Website"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Faster Asleep Smart Speaker Program",
                    "description": "Participants will receive a smart speaker device with a pre-loaded Faster Asleep program. Participants will be asked to engage with the program daily, either using the voice-activated speakers or an accompanying smart-phone app. The study duration is six-weeks and is completed individually using fully automated interaction to deliver components of cognitive behavioral therapy for insomnia.",
                    "armGroupLabels": [
                        "Voice-Activated Smart Speaker Program"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Faster Asleep Website",
                    "description": "Controls will have access to a website with information about CBT-I and breast cancer survivorship and will be told to engage with the website as desired. The content will be drawn from the education script that is programmed into the phone app accompanying the smart speaker program.",
                    "armGroupLabels": [
                        "Website"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Insomnia Symptoms",
                    "description": "Data will be collected on the Insomnia Severity Index (ISI) total score pre- and post-intervention as our primary outcome. The ISI is a seven-item questionnaire with response categories from 0-4 (total score 0-28) asking about sleep patterns and specifically characterizing insomnia over the two weeks prior. The ISI defines 'no clinically significant' insomnia as a score of 0-7, 'sub-threshold' insomnia as a score of 8-14, 'moderate severity clinical' insomnia' a scores of 15-21, and 'severe clinical' insomnia as a score of 22-28. Clinically relevant target for success is to achieve sub-threshold or better scores (\u226414) among \\>80% of the intervention participants",
                    "timeFrame": "6 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Sleep efficiency",
                    "description": "Sleep efficiency is calculated by the total time sleeping over the total time in bed.",
                    "timeFrame": "6 weeks"
                },
                {
                    "measure": "Wake after sleep onset",
                    "description": "Amount of time awake during the night",
                    "timeFrame": "6 weeks"
                },
                {
                    "measure": "Sleep onset latency",
                    "description": "Time to fall asleep",
                    "timeFrame": "6 weeks"
                },
                {
                    "measure": "Total sleep time",
                    "description": "Total time asleep",
                    "timeFrame": "6 weeks"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "System usability scale",
                    "description": "A 10-item scale on general usability of technology. This provides a score of 0-100, with above 68 indicating better than average usability, where higher is better. This is a normalized score and not a percentage.",
                    "timeFrame": "6 weeks"
                },
                {
                    "measure": "Sleep quality",
                    "description": "5-item Likert scale from Very Poor to Very Good.",
                    "timeFrame": "6 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Willingness to maintain a consistent dosing pattern if currently taking sleep medications or using cannabis for sleep\n* Females; Age 18+\n* Self-reported or documented diagnosis of breast cancer stage I-III or stage IV ECOG 0-1\n* Completed curative treatment (surgery, radiation, chemotherapy) \\> 3 months prior to enrollment \\[ongoing adjuvant therapy permitted\\]\n* Has not undergone other behavioral sleep treatment within the prior 12 months\n* Score greater than or equal to 8 on the Insomnia Severity Index\n* Able to understand and speak English\n\nExclusion Criteria:\n\n* Diagnosed, untreated obstructive sleep apnea syndrome, narcolepsy, restless leg syndrome, periodic limb movement disorder, delayed sleep phase syndrome, central apnea\n* Bi-polar disorder, schizophrenia, initiation of psychological treatment within three months, alcohol or drug abuse in the prior year (Alcohol \\>2 drinks/day or consuming 5+ drinks in a single day in the prior month). (Moderate ADHD, depression and anxiety will not be exclusion criteria.)\n* Shift-work in the prior three months or anticipated during the study time\n* Planned regular travel out of time zone (\\>1 hour) during the study period.\n* Currently or planning to become pregnant during the study period",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Hannah Arem, PhD",
                    "role": "CONTACT",
                    "phone": "202-893-2430",
                    "email": "Hannah.Arem@MedStar.net"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Hannah Arem, PhD",
                    "affiliation": "Medstar Health Research Institute",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "MedStar Washington Hospital Center",
                    "status": "RECRUITING",
                    "city": "Washington",
                    "state": "District of Columbia",
                    "zip": "20010",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Claire Starling",
                            "role": "CONTACT",
                            "email": "Claire.M.Starling@medstar.net"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.89511,
                        "lon": -77.03637
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "35729605",
                    "type": "DERIVED",
                    "citation": "Starling CM, Greenberg D, Zhou E, Lewin D, Morrow AS, Lieberman D, Shaw C, Arem H. Testing delivery of components of cognitive behavioral therapy for insomnia to breast cancer survivors by smart speaker: a study protocol. BMC Med Inform Decis Mak. 2022 Jun 21;22(1):163. doi: 10.1186/s12911-022-01902-w."
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001943",
                    "term": "Breast Neoplasms"
                },
                {
                    "id": "D000007319",
                    "term": "Sleep Initiation and Maintenance Disorders"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000001941",
                    "term": "Breast Diseases"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000020919",
                    "term": "Sleep Disorders, Intrinsic"
                },
                {
                    "id": "D000020920",
                    "term": "Dyssomnias"
                },
                {
                    "id": "D000012893",
                    "term": "Sleep Wake Disorders"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5220",
                    "name": "Breast Neoplasms",
                    "asFound": "Breast Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10356",
                    "name": "Sleep Initiation and Maintenance Disorders",
                    "asFound": "Insomnia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5218",
                    "name": "Breast Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22242",
                    "name": "Parasomnias",
                    "relevance": "LOW"
                },
                {
                    "id": "M22654",
                    "name": "Sleep Disorders, Intrinsic",
                    "relevance": "LOW"
                },
                {
                    "id": "M22655",
                    "name": "Dyssomnias",
                    "relevance": "LOW"
                },
                {
                    "id": "M15696",
                    "name": "Sleep Wake Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        }
    },
    "hasResults": false
}